This is a significant milestone for DUHS, and the visit from Dr. Kaine is an excellent opportunity to showcase the (PQM+) and the high-quality services provided by DUHS.
 

A Letter of Understanding (LoU) has been signed with United States Pharmacopeia (USP) & Promoting the Quality of Medicines Plus (PQM+). Dr. Emily Kaine, Senior Vice President of Global Health and Manufacturing Services at the US Pharmacopeia, recently visited the DUHS Bioequivalence Study Centre, Volunteer Health Care Facility (VHCF), and other DUHS Facilities to see the (PQM+).

The visit will also help to strengthen the partnership between DUHS and USP (PQM+), which will undoubtedly lead to further advancements in healthcare and manufacturing services.